{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:20:21Z","timestamp":1794010821084,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903761"],"award-info":[{"award-number":["81903761"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.biopha.2023.116089","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T17:23:41Z","timestamp":1703784221000},"page":"116089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Selection and evaluation of quality markers for the regulation of PXR-CYP3A4\/FXR-LXR\u03b1 by Exocarpium Citri Grandis for the treatment of hyperlipidaemia with dispelling blood stasis and removing phlegm"],"prefix":"10.1016","volume":"170","author":[{"given":"Guangying","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanlin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canchao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.116089_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104272","article-title":"Metabolomic-based investigation of Yinlan alleviating hyperlipidemia by inhibiting blood stasis and phlegm turbidity through the PXR-CYP3A4-ABCB1-FXR pathway","volume":"15","author":"Li","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.biopha.2023.116089_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2022.108981","article-title":"Bile acid-based receptors and their applications in recognition","volume":"179","author":"Patel","year":"2022","journal-title":"Steroids"},{"key":"10.1016\/j.biopha.2023.116089_bib3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.bbadis.2017.09.019","article-title":"Nuclear receptor FXR, bile acids and liver damage: introducing the progressive familial intrahepatic cholestasis with FXR mutations","volume":"1864","author":"Cariello","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2023.116089_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.livres.2019.01.001","article-title":"Bile acid receptors and gastrointestinal functions","volume":"3","author":"Ticho","year":"2019","journal-title":"Liver Res."},{"key":"10.1016\/j.biopha.2023.116089_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.livres.2021.08.003","article-title":"Bile acid activated receptors: integrating immune and metabolic regulation in non-alcoholic fatty liver disease","volume":"5","author":"Biagioli","year":"2021","journal-title":"Liver Res."},{"key":"10.1016\/j.biopha.2023.116089_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174841","article-title":"Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR\/SHP\/SREBP-1c axis","volume":"921","author":"Peng","year":"2022","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2023.116089_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105558","article-title":"Lipidomic analysis of human primary hepatocytes following LXR activation with GW3965 identifies AGXT2L1 as a main target associated to changes in phosphatidylethanolamine","volume":"198","author":"Santinha","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2023.116089_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.toxlet.2022.02.002","article-title":"A biologically based model to quantitatively assess the role of the nuclear receptors liver X (LXR), and pregnane X (PXR) on chemically induced hepatic steatosis","volume":"359","author":"Bay","year":"2022","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2023.116089_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108794","article-title":"Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR\/LXRs-dependent manner","volume":"311","author":"Han","year":"2019","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.biopha.2023.116089_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132464","article-title":"A comprehensive strategy integrating metabolomics with multiple chemometric for discovery of function related active markers for assessment of foodstuffs: a case of hawthorn (Crataegus cuneata) fruits","volume":"383","author":"Cui","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.biopha.2023.116089_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115879","article-title":"Neoline, fuziline, songorine and 10-OH mesaconitine are potential quality markers of Fuzi: In vitro and in vivo explorations as well as pharmacokinetics, efficacy and toxicity evaluations","volume":"303","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2023.116089_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104281","article-title":"Screening and characterizing the quality markers of Selaginella tamariscina (P. Beauv.) Spring using metabonomics and molecular networking","volume":"15","author":"Zhang","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.biopha.2023.116089_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.aca.2017.07.058","article-title":"An alignment algorithm for LC-MS-based metabolomics dataset assisted by MS\/MS information","volume":"990","author":"Li","year":"2017","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.biopha.2023.116089_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.161861","article-title":"Identification of biomarkers for risk assessment of arsenicosis based on untargeted metabolomics and machine learning algorithms","volume":"870","author":"Zhang","year":"2023","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.biopha.2023.116089_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2022.111512","article-title":"A comparative UHPLC-Q\/TOF-MS-based metabolomics approach coupled with machine learning algorithms to differentiate Keemun black teas from narrow-geographic origins","volume":"158","author":"Peng","year":"2022","journal-title":"Food Res. Int."},{"key":"10.1016\/j.biopha.2023.116089_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105402","article-title":"Pyrazinamide alleviates rifampin-induced steatohepatitis in mice by regulating the activities of cholesterol-activated 7\u03b1-hydroxylase and lipoprotein lipase","volume":"151","author":"Tan","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.116089_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115159","article-title":"Probing PXR activation and modulation of CYP3A4 by Tinospora crispa and Tinospora sinensis","volume":"291","author":"Parveen","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2023.116089_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04278-2","article-title":"The role of bile acids in carcinogenesis","volume":"79","author":"Re\u017een","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2023.116089_bib19","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.emboj.7601049","article-title":"Endocrine functions of bile acids","volume":"25","author":"Houten","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2023.116089_bib20","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jcmgh.2021.01.012","article-title":"Transcriptional regulation of metabolic pathways via lipid-sensing nuclear receptors PPARs, FXR, and LXR in NASH","volume":"11","author":"Cariello","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2023.116089_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166235","article-title":"Nuclear receptors in liver fibrosis","volume":"1867","author":"K\u00f6nigshofer","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2023.116089_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jhep.2020.07.048","article-title":"miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder","volume":"74","author":"Fan","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2023.116089_bib23","article-title":"Selection and evaluation of quality control markers in propolis based on its hyperlipidemia therapy via regulating PXR\/CYP3A4 expression","volume":"1","author":"Chen","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2023.116089_bib24","article-title":"The anti-hyperlipidemia effect of Yinlan capsule via regulation of PXR activity","volume":"1","author":"Chen","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2023.116089_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/03602532.2012.743560","article-title":"Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development","volume":"45","author":"Sinz","year":"2013","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.biopha.2023.116089_bib26","first-page":"4221","article-title":"Beneficial effects of Naringin against lopinavir\/ ritonavir-induced hyperlipidemia and reproductive toxicity in male albino rats","volume":"27","author":"Krishnaraju","year":"2023","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.116089_bib27","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.pharep.2015.04.002","article-title":"Naringenin protects cardiac hypercholesterolemia-induced oxidative stress and subsequent necroptosis in rats","volume":"67","author":"Chtourou","year":"2015","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.biopha.2023.116089_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7615830","article-title":"Phenolic compounds of propolis alleviate lipid metabolism disorder","volume":"2021","author":"Kong","year":"2021","journal-title":"Evid. Based Complement Altern. Med."},{"key":"10.1016\/j.biopha.2023.116089_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jsbmb.2011.06.012","article-title":"FXR and PXR: potential therapeutic targets in cholestasis","volume":"130","author":"Jonker","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2023.116089_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.959902","article-title":"The role of pregnane X receptor (PXR) in substance metabolism","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"Suppl 10","key":"10.1016\/j.biopha.2023.116089_bib31","article-title":"Developmental changes in pharmacokinetics and pharmacodynamics","volume":"58","author":"van den Anker","year":"2018","journal-title":"J. Clin. Pharm."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223018875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223018875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:46:43Z","timestamp":1773967603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223018875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":31,"alternative-id":["S0753332223018875"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.116089","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selection and evaluation of quality markers for the regulation of PXR-CYP3A4\/FXR-LXR\u03b1 by Exocarpium Citri Grandis for the treatment of hyperlipidaemia with dispelling blood stasis and removing phlegm","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.116089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116089"}}